New radioactive combo targets Hard-to-Treat tumors
NCT ID NCT06640413
First seen Jan 15, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This early-phase study tests a new radioactive drug, alone or with an immune-boosting drug, in people with advanced solid tumors that have a specific marker called FAP. The main goal is to find a safe dose and check for side effects. About 56 adults whose cancer has worsened after standard treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAP are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Papa Giovanni XXIII Piazza OMS
RECRUITINGBergamo, Bergamo, 24127, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Milano, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Istituto Europeo di Oncologia
NOT_YET_RECRUITINGMilan, Milano, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Via Mariano Semmola
NOT_YET_RECRUITINGNaples, Napoli, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.